Institute For Wealth Management, Llc. Amgen Inc Transaction History

Institute For Wealth Management, Llc.

$781 Million
Q3 2024

A detailed history of Institute For Wealth Management, Llc. transactions in Amgen Inc stock. As of the latest transaction made, Institute For Wealth Management, Llc. holds 12,391 shares of AMGN stock, worth $3.26 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

12,391

Previous 12,520 1.03%

Holding current value

$3.26 Million

Previous $3.91 Million 2.07%

% of portfolio

0.51%

Previous 0.53%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $39,910 - $43,522	-129 Reduced 1.03%	12,391 $3.99 Million
Q2 2024 Jul 25, 2024	BUY	$262.75 - $319.31 $48,608 - $59,072	185 Added 1.5%	12,520 $3.91 Million
Q1 2024 Apr 30, 2024	SELL	$268.87 - $324.56 $69,637 - $84,061	-259 Reduced 2.06%	12,335 $3.51 Million
Q4 2023 Jan 31, 2024	SELL	$255.7 - $288.46 $33,496 - $37,788	-131 Reduced 1.03%	12,594 $3.63 Million
Q3 2023 Oct 13, 2023	SELL	$218.65 - $271.46 $21,209 - $26,331	-97 Reduced 0.76%	12,725 $3.42 Million
Q2 2023 Jul 25, 2023	SELL	$214.27 - $253.37 $80,994 - $95,773	-378 Reduced 2.86%	12,822 $2.85 Million
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $59,608 - $72,652	-264 Reduced 1.96%	13,200 $3.19 Million
Q4 2022 Feb 02, 2023	SELL	$229.03 - $291.01 $28,857 - $36,667	-126 Reduced 0.93%	13,464 $3.54 Million
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $8,080 - $9,113	-36 Reduced 0.26%	13,590 $3.06 Million
Q2 2022 Jul 25, 2022	SELL	$230.71 - $256.74 $4,844 - $5,391	-21 Reduced 0.15%	13,626 $3.32 Million
Q1 2022 Apr 29, 2022	SELL	$219.27 - $242.57 $16,883 - $18,677	-77 Reduced 0.56%	13,647 $3.3 Million
Q4 2021 Jan 21, 2022	BUY	$198.88 - $227.6 $37,389 - $42,788	188 Added 1.39%	13,724 $3.09 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $79,813 - $93,511	376 Added 2.86%	13,536 $2.88 Million
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $80,585 - $89,403	-345 Reduced 2.55%	13,160 $3.21 Million
Q1 2021 May 04, 2021	SELL	$221.91 - $258.6 $86,322 - $100,595	-389 Reduced 2.8%	13,505 $3.36 Million
Q4 2020 Feb 01, 2021	SELL	$216.38 - $257.67 $67,510 - $80,393	-312 Reduced 2.2%	13,894 $3.19 Million
Q3 2020 Nov 03, 2020	SELL	$234.65 - $260.95 $326,163 - $362,720	-1,390 Reduced 8.91%	14,206 $3.61 Million
Q2 2020 Jul 30, 2020	SELL	$197.81 - $242.74 $97,915 - $120,156	-495 Reduced 3.08%	15,596 $3.68 Million
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $135,951 - $180,308	-746 Reduced 4.43%	16,091 $3.26 Million
Q4 2019 Feb 27, 2020	BUY	$189.21 - $243.2 $2.42 Million - $3.11 Million	12,778 Added 314.81%	16,837 $4.06 Million
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $2.37 Million - $3.05 Million	-12,549 Reduced 75.56%	4,059 $4.06 Million
Q3 2019 Oct 28, 2019	SELL	$174.11 - $208.62 $208,235 - $249,509	-1,196 Reduced 6.72%	16,608 $3.21 Million
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $237,047 - $277,873	1,422 Added 8.68%	17,804 $3.28 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $311,277 - $350,877	-1,721 Reduced 9.51%	16,382 $3.11 Million
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $819,212 - $956,284	4,592 Added 33.99%	18,103 $3.52 Million
Q3 2018 Oct 29, 2018	SELL	$185.29 - $208.89 $306,284 - $345,295	-1,653 Reduced 10.9%	13,511 $2.8 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $136,327 - $153,124	821 Added 5.72%	15,164 $2.79 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $530,993 - $620,532	3,134 Added 27.96%	14,343 $2.47 Million
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $162,544 - $181,612	-963 Reduced 7.91%	11,209 $1.94 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $161,100 - $183,933	963 Added 8.59%	12,172 $2.28 Million
Q2 2017 Aug 14, 2017	BUY	N/A	11,209	11,209 $1.93 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Institute For Wealth Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Institute For Wealth Management, Llc. with notifications on news.

Account

Institute For Wealth Management, Llc. Amgen Inc Transaction History